Two monoclonal antibodies detecting allotypic determinants of HLA-A. 1983

S Minami, and R Ueda, and T Shiraki, and M Tanimoto, and R Namikawa, and M Seto, and K Nishida, and I Tsuge, and K Ota, and T Takahashi

Three mouse hybridomas producing cytotoxic antibodies against HLA were established. By standard microcytotoxicity test against panels of normal controls, the antigen defined by MA-9 antibody (IgM) showed a good correlation with HLA-A9 alloantigen detected by conventional typing alloantisera (r = 1.0). Family studies also showed that MA-9 determinant segregated with HLA-A9. MA-10 antibody (IgM) reacted with all HLA-A10 positive lymphocyte donors and cross-reacted with two thirds of HLA-AW33 positive donors. Ml-1 antibody (IgG2a) reacted with all the panel cells tested and immunoprecipitated a molecule of 43,000 daltons from Nonidet P-40 lysates of 3H-glucosamine-labelled cells. The results showed that MA-9 and MA-10 antibodies can be used as routine tissue typing reagents.

UI MeSH Term Description Entries
D007519 Isoantigens Antigens that exist in alternative (allelic) forms in a single species. When an isoantigen is encountered by species members who lack it, an immune response is induced. Typical isoantigens are the BLOOD GROUP ANTIGENS. Alloantigens,Alloantigen,Isoantigen
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D005260 Female Females
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006825 Hybridomas Cells artificially created by fusion of activated lymphocytes with neoplastic cells. The resulting hybrid cells are cloned and produce pure MONOCLONAL ANTIBODIES or T-cell products, identical to those produced by the immunologically competent parent cell. Hybridoma

Related Publications

S Minami, and R Ueda, and T Shiraki, and M Tanimoto, and R Namikawa, and M Seto, and K Nishida, and I Tsuge, and K Ota, and T Takahashi
July 1984, British medical bulletin,
S Minami, and R Ueda, and T Shiraki, and M Tanimoto, and R Namikawa, and M Seto, and K Nishida, and I Tsuge, and K Ota, and T Takahashi
January 1982, Journal of immunology (Baltimore, Md. : 1950),
S Minami, and R Ueda, and T Shiraki, and M Tanimoto, and R Namikawa, and M Seto, and K Nishida, and I Tsuge, and K Ota, and T Takahashi
July 1980, Tissue antigens,
S Minami, and R Ueda, and T Shiraki, and M Tanimoto, and R Namikawa, and M Seto, and K Nishida, and I Tsuge, and K Ota, and T Takahashi
April 1983, Medical biology,
S Minami, and R Ueda, and T Shiraki, and M Tanimoto, and R Namikawa, and M Seto, and K Nishida, and I Tsuge, and K Ota, and T Takahashi
January 1983, Immunogenetics,
S Minami, and R Ueda, and T Shiraki, and M Tanimoto, and R Namikawa, and M Seto, and K Nishida, and I Tsuge, and K Ota, and T Takahashi
January 1983, Immunogenetics,
S Minami, and R Ueda, and T Shiraki, and M Tanimoto, and R Namikawa, and M Seto, and K Nishida, and I Tsuge, and K Ota, and T Takahashi
June 1983, Journal of immunology (Baltimore, Md. : 1950),
S Minami, and R Ueda, and T Shiraki, and M Tanimoto, and R Namikawa, and M Seto, and K Nishida, and I Tsuge, and K Ota, and T Takahashi
January 1985, Hybridoma,
S Minami, and R Ueda, and T Shiraki, and M Tanimoto, and R Namikawa, and M Seto, and K Nishida, and I Tsuge, and K Ota, and T Takahashi
January 1985, Immunology letters,
S Minami, and R Ueda, and T Shiraki, and M Tanimoto, and R Namikawa, and M Seto, and K Nishida, and I Tsuge, and K Ota, and T Takahashi
December 1979, Molecular immunology,
Copied contents to your clipboard!